Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Xtant Medical Hldgs Q4 EPS $(0.02) Misses $(0.01) Estimate, Sales $31.51M Miss $31.80M Estimate

Author: Benzinga Newsdesk | March 06, 2025 05:18pm
Xtant Medical Hldgs (AMEX:XTNT) reported quarterly losses of $(0.02) per share which missed the analyst consensus estimate of $(0.01) by 100 percent. This is a 33.33 percent increase over losses of $(0.03) per share from the same period last year. The company reported quarterly sales of $31.51 million which missed the analyst consensus estimate of $31.80 million by 0.90 percent. This is a 12.11 percent increase over sales of $28.11 million the same period last year.

Posted In: XTNT

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist